1-fluoro-3-chloropropane | CAS:462-38-4

We serve 1-fluoro-3-chloropropane CAS:462-38-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1-fluoro-3-chloropropane

Chemical Name:1-fluoro-3-chloropropane
CAS.NO:462-38-4
Synonyms:1-fluoro-3-chloropropane
1-Chlor-3-fluorpropan
hydrochlorofluoropropane
3-Chlor-propylchloride
3-Chlor-propylfluoride
Molecular Formula:C3H6ClF
Molecular Weight:96.5311432
 
Physical and Chemical Properties:
Density:1.5081
Melting point:-59ºC
Boiling point:69.68ºC
Index of Refraction:1.3871
 
Specification:
Appearance:Colorless transparent liquid
Assay:≥99.0%
Moisture:≤0.05%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 1-fluoro-3-chloropropane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Chlor-propylfluoride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Chlor-3-fluorpropan Use and application,3-Chlor-propylchloride technical grade,usp/ep/jp grade.


Related News: In order to find answers to these questions, our staff in the development department set about conducting a series of experiments.2-methyl-1,4-phenylenediamine manufacturer China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%.8-Bromo-3-methyl-1H-purine-2,6(3H,7H)-dione supplier Since inception in 2004, ICIG has acquired 15 businesses, all of which have origins in major global chemical or pharmaceutical corporations and are independently managed.6-fluorohexan-1-ol vendor Australia’s ban followed an earlier move by the US Friday to deny entry to foreign nationals who have traveled in China in the last 14 days.Our pharma and biotech offering includes registration and commercialization of products through in-licensing and flexible partnerships.